NCT00002146View on ClinicalTrials.gov

Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

Not specified

Conditions
Cytomegalovirus InfectionsHIV InfectionsHypocalcemia
Interventions
DRUG

Magnesium sulfate

DRUG

Foscarnet sodium

Trial Locations (1)

731045028

Oklahoma City Veterans Administration Med Ctr, Oklahoma City

Sponsors

Lead Sponsor

Astra USA
All Listed Sponsors
lead

Astra USA

INDUSTRY

NCT00002146 - Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study | Biotech Hunter | Biotech Hunter